MEDIWILL
ActiveMEDIWILL has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.00M and a net result of €433k. Equity is growing by ~52.8% per year across the filed fiscal years. Its solvency ranks better than 90% of 636 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
98
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability93▼-4
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €190k at 30 days acceptable
Liquidity ample (current ratio 8.72 against 5.85 in 2024; short-term debt: 10.3% and cash: 56.5% of total assets), and 10.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
89.7%
Return on assets
19.4%
Age of the figures
13 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-08-2025 was due by 31-03-2026 and was filed on 25-03-2026, 6 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
6 d early
2024
1 d late
2023
8 d late
2022
19 d late
2021
on the day
2020
30 d late
2019
44 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-08-2026 and is due by 31-03-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
31-08-2026 close20-09-2026 today31-03-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€433k▼ 3.4%
2024 · €449k
2019: €143k
2020: €104k
2021: €246k
2022: €395k
2023: €346k
2024: €449k
2019 → 2025
Working capital
€1.78M▲ 27.1%
2024 · €1.40M
2019: €42k
2020: €108k
2021: €334k
2022: €676k
2023: €915k
2024: €1.40M
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€529k-€925k▲ 74.7%€1.24M▲ 33.7%€1.68M▲ 36.3%€2.00M▲ 18.9%
Operating result€353k-€556k▲ 57.8%€498k▼ 10.4%€619k▲ 24.1%€611k▼ 1.2%
Net result€246k-€395k▲ 60.7%€346k▼ 12.4%€449k▲ 29.6%€433k▼ 3.4%
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 1% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.23M
Fixed assets
€225k▼ 25.6%
Current assets
€2.01M▲ 19.0%
Equity and liabilities €2.23M
Equity
€2.00M▲ 18.9%
Debt
€231k▼ 24.3%
The debt ratio falls from 15.3% to 10.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€694k▼
2024 · €701k
Cash flow
€516k▼
2024 · €531k
Solvency
89.7%▲
2024 · 84.7%
Current ratio
8.72▲
2024 · 5.85
Quick ratio
8.72▲
2024 · 5.85
Debt / equity
0.12▼
2024 · 0.18
ROE
21.6%▼
2024 · 26.6%
ROA
19.4%▼
2024 · 22.5%
Interest coverage
635.85▲
2024 · 197.38
Debt
€231k▼
2024 · €305k
Debt ≤ 1 year
€230k▼
2024 · €289k
Income taxes
€185k▲
2024 · €178k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.99M€2.23M▲
Fixed assets21/28€302k€225k▼
Tangible fixed assets22/27€302k€225k▼
Land and buildings22€179k€144k▼
Furniture and vehicles24€78k€44k▼
Other tangible fixed assets26€44k€38k▼
Current assets29/58€1.69M€2.01M▲
Amounts receivable within one year40/41€132k€116k▼
Trade receivables40€95k€87k▼
Other amounts receivable41€37k€29k▼
Current investments50/53€125k€500k▲
Cash at bank and in hand54/58€1.28M€1.26M▼
Deferred charges and accrued income490/1€147k€131k▼
Equity and liabilities
Total equity and liabilities10/49€1.99M€2.23M▲
Equity10/15€1.68M€2.00M▲
Contributions10/11€25k€25k=
Reserves13€1.66M€1.98M▲
Non-distributable reserves130/1€5k€5k=
Reserves not available under the articles1311€5k€5k=
Tax-exempt reserves132€694k€842k▲
Distributable reserves133€961k€1.13M▲
Amounts payable17/49€305k€231k▼
Amounts payable after more than one year17€14k-
Financial debts170/4€14k-
Amounts payable within one year42/48€289k€230k▼
Current portion of amounts payable after more than one year42€55k€14k▼
Trade debts44€80k€80k▼
Suppliers440/4€80k€80k▼
Taxes, remuneration and social security45€29k€25k▼
Taxes450/3€23k€25k▲
Remuneration and social security454/9€6k-
Other amounts payable47/48€124k€112k▼
Accrued charges and deferred income492/3€3k€475▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€82k€83k▲
Other operating charges640/8€925€8k▲
Non-recurring operating charges66A€215€448▲
Gross operating margin9900€702k€702k=
Operating profit (loss)9901€619k€611k▼
Financial income75/76B€11k€9k▼
Recurring financial income75€11k€9k▼
Financial charges65/66B€4k€1k▼
Recurring financial charges65€4k€1k▼
Profit (loss) for the period before taxes9903€626k€619k▼
Income taxes67/77€178k€185k▲
Profit (loss) for the period9904€449k€433k▼
Transfer to tax-exempt reserves689€211k€147k▼
Profit (loss) for the period to be appropriated9905€238k€286k▲
Appropriation of the result
Profit (loss) to be appropriated9906€238k€286k▲
Transfer from equity791/2-€115k
Transfer to equity691/2€238k€286k▲
To other reserves6921€238k€286k▲
Profit to be distributed694/7-€115k
Return on contributions (dividend)694-€115k
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
25-03
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
31-08
Financial
Equity above €2MEq €2.00M ▲18.9%
7 profitable years in a row build equity to €2.00M.
01-04
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 1 day late
2024
31-08
Financial
Highest result since 2019net €449k ▲29.6%
Operating result €619k, net result €449k, both a record.
08-04
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 8 days late
2023
31-08
Financial
Equity above €1MEq €1.24M ▲33.7%
5 profitable years in a row build equity to €1.24M.
19-04
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 19 days late
2022
31-08
Financial
Liquidity doublescurrent ratio 4.32
Current ratio from 1.98 to 4.32; short-term debt falls from €341k to €203k.
31-03
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-08
Financial
Equity above €500kEq €529k ▲86.7%
3 profitable years in a row build equity to €529k.
30-04
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 30 days late
2020
31-08
Financial
Weakest financial yearnet €104k ▼27.4%
Net result drops to €104k, the lowest in the series; recovery starts the following year.
31-08
Financial
Equity above €200kEq €284k ▲57.9%
2 profitable years in a row build equity to €284k.
14-05
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 44 days late
2019
26-04
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 26 days late
2018
30-04
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 30 days late
2017
24-04
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 24 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Rixensart · 3 establishment units since 2000
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Avenue Gevaert 1511332 RixensartGround area
2,656 m²
Building footprint
481 m²
Volume, LiDAR
2,805 m³
3 parcels, Wallonia · tallest building 8.9 m, ±2 floors. Linked by address, not a title deed.
3 establishment units
Promenade du Val d'Argent 16, 1310 La Hulpe
since 20002.271.746.037
Avenue Reine Astrid 59, 1310 La Hulpe
since 20002.271.746.235
Avenue Gevaert 151, 1332 Rixensart
since 20102.271.749.502
3 parcels
Wallonia
3
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25033D0154/00K000 | Wallonia | 1,485 m² | 1 · 203 m² | 8.9 m · 2 fl. |
| 25050C0107/00N002 | Wallonia | 742 m² | 1 · 153 m² | 7.8 m · 2 fl. |
| 25050D0047/00E000 ProtectedSite or landscape |
Wallonia | 428 m² | 1 · 126 m² | 7.9 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 2
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Similar companies · same sector, comparable size
Bredabaan 552
BE 0829.489.461
Brasschaat · Eq €2.01M
DOKTER BART STUYTS
BE 0874.834.783
Schilde · Eq €2.01M
SA Artsen
BE 0899.054.002
Roeselare · Eq €2.01M
DOKTER DEBOEVER GUIDO
BE 0826.763.365
Oostende · Eq €2.00M
Dr H. Mertens-Radioloog
BE 0884.661.576
Genk · Eq €2.00M
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 4,628 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded29-11-2000
Fiscal year end31-08
Activities, NACEBEL
86220Specialist medical practice
74909Other professional, scientific and technical activities
74999Other professional, scientific and technical activities
86901Human health activities
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 25 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.